TEST BANK c
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
c c c c c c c
Author: Teri Moser Woo and Wendy L. Wright
c c c c c c c
, TABLE OF CONTENT c c
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ...................................................................... 4
c c c c c c c c c c
Chapter 2. Review of Basic Principles of Pharmacology ...................................................................................... 5
c c c c c c c
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
c c c c
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
c c c c c c c
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
c c c c
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
c c c c c
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
c c c c
Chapter 8. Herbal Therapies ................................................................................................................................ 28
c c c
Chapter 9. Cannabis ............................................................................................................................................ 31
c c
Chapter 10. Pharmacoeconomics......................................................................................................................... 35
c c
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
c c c c c c c
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
c c c c c c c
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
c c c c c c c c
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
c c c c c c
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
c c c c c c
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
c c c c c c c c c
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
c c c c c c c
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
c c c c c c
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs.................... 80
c c c c c c c c c c c
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
c c c c c c c c c c c
Chapter 21. Drugs Affecting the Reproductive System....................................................................................... 86
c c c c c c
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
c c c c c c c
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
c c c c c c
Chapter 24. Drugs Used to Treat Bacterial Infections ....................................................................................... 101
c c c c c c c
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................ 105
c c c c c c c c c c
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................ 108
c c c c c c c
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
c c c c c c c c c
Chapter 28. Anemia........................................................................................................................................... 113
c c
Chapter 29. Anxiety and Depression ................................................................................................................. 116
c c c c
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
c c c c
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
c c c c
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
c c c c c
Chapter 33. Contraception ................................................................................................................................. 127
c c
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
c c c c c
Chapter 35. Dermatological Conditions ............................................................................................................ 134
c c c
Chapter 36. Diabetes Management .................................................................................................................... 138
c c c
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease....................................................................... 146
c c c c c c c
Chapter 38. Headaches ...................................................................................................................................... 149
c c
Chapter 39. Heart Failure .................................................................................................................................. 153
c c c
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
c c c c c c c
Chapter 41. Menopausal Hormone Therapy...................................................................................................... 161
c c c c
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
c c
Chapter 43. Hypertension .................................................................................................................................. 169
c c
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
c c c c
Chapter 45. Obesity ........................................................................................................................................... 177
c c
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
c c c c c c c
Chapter 47. Pneumonia ..................................................................................................................................... 185
c c
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
c c c c c c
Chapter 49. Substance Use Disorders ................................................................................................................ 190
c c c c
Chapter 50. Tuberculosis ................................................................................................................................... 195
c c
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
c c c c c c c c c c c c
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
c c c c
Chapter 53. Women as Patients ......................................................................................................................... 203
c c c c
Chapter 54. Men as Patients .............................................................................................................................. 207
c c c c
Chapter 55. Pediatric Patients ............................................................................................................................ 209
c c c
Chapter 57. Geriatric Patients ............................................................................................................................ 213
c c c
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e c c c c Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
c c c c c c c c c c
MULTIPLE CHOICE c
1. Nurse practitioner prescriptive authority is regulated by:
c c c c c c
A. The National Council of State Boards of Nursing
c c c c c c c
B. The U.S. Drug Enforcement Administration
c c c c
C. The State Board of Nursing for each state
c c c c c c c
D. The State Board of Pharmacy
c c c c
ANS: C c PTS: c c 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
c c c c c c c c c c c c c
cinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
c c c c c c c c c c c
both in their basic nursing program and in their APRN program.
c c c c c c c c c c c
B. Nurses care for the patient from a holistic approach and include the patient in
c c c c c c c c c c c c c
decision-making regarding their care.
c c c c
C. APRNs are less likely to prescribe narcotics and other controlled substances.
c c c c c c c c c c
D. APRNs are able to prescribe independently in all states, whereas a physician’s
c c c c c c c c c c c
assistant needs to have a physician supervising their practice.
c c c c c c c c c
ANS: B c PTS: c c 1
3. Clinical judgment in prescribing includes:
c c c c
A. Factoring in the cost to the patient of the medication prescribed
c c c c c c c c c c
B. Always prescribing the newest medication available for the disease process
c c c c c c c c c
C. Handing out drug samples to poor patients c c c c c c
D. Prescribing all generic medications to cut costs c c c c c c
ANS: A c PTS: c c 1
4. The process for choosing an effective drug for a disorder includes:
c c c c c c c c c c
A. Asking the patient what drug they think would work best for them
c c c c c c c c c c c
B. Consulting nationally recognized guidelines for disease management
c c c c c c
C. Prescribing medications that are available as samples before writing a prescription
c c c c c c c c c c
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
c c c c c c c
ANS: B c PTS: c c 1
5. Nonintentional nonadherence of drug therapy may occur due to: c c c c c c c c
A. Belief that medication does not work
c c c c c
B. Adverse drug reactions c c
C. Chronic conditions that require daily therapy
c c c c c
D. Forgetfulness or distraction c c
ANS: D c PTS: c c 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
c c c c c c c
Author: Teri Moser Woo and Wendy L. Wright
c c c c c c c
, TABLE OF CONTENT c c
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ...................................................................... 4
c c c c c c c c c c
Chapter 2. Review of Basic Principles of Pharmacology ...................................................................................... 5
c c c c c c c
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
c c c c
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
c c c c c c c
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
c c c c
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
c c c c c
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
c c c c
Chapter 8. Herbal Therapies ................................................................................................................................ 28
c c c
Chapter 9. Cannabis ............................................................................................................................................ 31
c c
Chapter 10. Pharmacoeconomics......................................................................................................................... 35
c c
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
c c c c c c c
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
c c c c c c c
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
c c c c c c c c
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
c c c c c c
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
c c c c c c
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
c c c c c c c c c
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
c c c c c c c
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
c c c c c c
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs.................... 80
c c c c c c c c c c c
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
c c c c c c c c c c c
Chapter 21. Drugs Affecting the Reproductive System....................................................................................... 86
c c c c c c
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
c c c c c c c
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
c c c c c c
Chapter 24. Drugs Used to Treat Bacterial Infections ....................................................................................... 101
c c c c c c c
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................ 105
c c c c c c c c c c
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................ 108
c c c c c c c
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
c c c c c c c c c
Chapter 28. Anemia........................................................................................................................................... 113
c c
Chapter 29. Anxiety and Depression ................................................................................................................. 116
c c c c
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
c c c c
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
c c c c
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
c c c c c
Chapter 33. Contraception ................................................................................................................................. 127
c c
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
c c c c c
Chapter 35. Dermatological Conditions ............................................................................................................ 134
c c c
Chapter 36. Diabetes Management .................................................................................................................... 138
c c c
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease....................................................................... 146
c c c c c c c
Chapter 38. Headaches ...................................................................................................................................... 149
c c
Chapter 39. Heart Failure .................................................................................................................................. 153
c c c
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
c c c c c c c
Chapter 41. Menopausal Hormone Therapy...................................................................................................... 161
c c c c
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
c c
Chapter 43. Hypertension .................................................................................................................................. 169
c c
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
c c c c
Chapter 45. Obesity ........................................................................................................................................... 177
c c
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
c c c c c c c
Chapter 47. Pneumonia ..................................................................................................................................... 185
c c
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
c c c c c c
Chapter 49. Substance Use Disorders ................................................................................................................ 190
c c c c
Chapter 50. Tuberculosis ................................................................................................................................... 195
c c
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
c c c c c c c c c c c c
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
c c c c
Chapter 53. Women as Patients ......................................................................................................................... 203
c c c c
Chapter 54. Men as Patients .............................................................................................................................. 207
c c c c
Chapter 55. Pediatric Patients ............................................................................................................................ 209
c c c
Chapter 57. Geriatric Patients ............................................................................................................................ 213
c c c
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e c c c c Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
c c c c c c c c c c
MULTIPLE CHOICE c
1. Nurse practitioner prescriptive authority is regulated by:
c c c c c c
A. The National Council of State Boards of Nursing
c c c c c c c
B. The U.S. Drug Enforcement Administration
c c c c
C. The State Board of Nursing for each state
c c c c c c c
D. The State Board of Pharmacy
c c c c
ANS: C c PTS: c c 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
c c c c c c c c c c c c c
cinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
c c c c c c c c c c c
both in their basic nursing program and in their APRN program.
c c c c c c c c c c c
B. Nurses care for the patient from a holistic approach and include the patient in
c c c c c c c c c c c c c
decision-making regarding their care.
c c c c
C. APRNs are less likely to prescribe narcotics and other controlled substances.
c c c c c c c c c c
D. APRNs are able to prescribe independently in all states, whereas a physician’s
c c c c c c c c c c c
assistant needs to have a physician supervising their practice.
c c c c c c c c c
ANS: B c PTS: c c 1
3. Clinical judgment in prescribing includes:
c c c c
A. Factoring in the cost to the patient of the medication prescribed
c c c c c c c c c c
B. Always prescribing the newest medication available for the disease process
c c c c c c c c c
C. Handing out drug samples to poor patients c c c c c c
D. Prescribing all generic medications to cut costs c c c c c c
ANS: A c PTS: c c 1
4. The process for choosing an effective drug for a disorder includes:
c c c c c c c c c c
A. Asking the patient what drug they think would work best for them
c c c c c c c c c c c
B. Consulting nationally recognized guidelines for disease management
c c c c c c
C. Prescribing medications that are available as samples before writing a prescription
c c c c c c c c c c
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
c c c c c c c
ANS: B c PTS: c c 1
5. Nonintentional nonadherence of drug therapy may occur due to: c c c c c c c c
A. Belief that medication does not work
c c c c c
B. Adverse drug reactions c c
C. Chronic conditions that require daily therapy
c c c c c
D. Forgetfulness or distraction c c
ANS: D c PTS: c c 1
